Clinical Trial Update: An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894 [Phase 2]

View source ↗

Summary

Extension phase 2 clinical trial to assess safety and efficacy of CRN04894 in participants with congenital adrenal hyperplasia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Congenital Adrenal Hyperplasia
• Congenital Adrenal Hyperplasia

Drugs mentioned

• CRN04894

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | Phase 2 | Status: RECRUITING